Glecaprevir

Glecaprevir Suppliers list
Company Name: Hangzhou FandaChem Co.,Ltd.
Tel: 008657128800458; +8615858145714
Email: fandachem@gmail.com
Products Intro: Product Name:glecaprevir
CAS:1365970-03-1
Purity:As coa Package:As request Remarks:1365970-03-1
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: CAS:1365970-03-1
Purity:98% Package:5MG;10MG;50MG;100MG,1G,5G
Company Name: TianYuan Pharmaceutical CO.,LTD
Tel: +86-755-23284190 13684996853
Email: sales@tianpharm.com
Products Intro: Product Name:Glecaprevir(ABT-493)
CAS:1365970-03-1
Purity:98% Package:10g 100g 200g 500g 1kg 5kg per barrel
Company Name: Huaian yishu technology co.,ltd
Tel: 86-0517-85883738 13852390259
Email: sales@yishuchem.com
Products Intro: Product Name:Glecaprevir API
CAS:1365970-03-1
Purity:99% Package:1000g
Company Name: career henan chemical co
Tel: +86-0371-86658258 15093356674;
Email: factory@coreychem.com
Products Intro: Product Name:Glecaprevir
CAS:1365970-03-1
Purity:99% Package:1KG;1USD

Glecaprevir manufacturers

  • Glecaprevir
  • Glecaprevir pictures
  • $1.00 / 1KG
  • 2020-01-03
  • CAS:1365970-03-1
  • Min. Order: 1KG
  • Purity: 99%
  • Supply Ability: 200kg

Related articles

  • Glecaprevir-Pibrentasvir (Mavyret)
  • MAVYRET is a prescription medicine used to treat adults and children 12 years of age and older or weighing at least 99 pounds ....
  • Dec 21,2021
Glecaprevir Basic information
Approval
Product Name:Glecaprevir
Synonyms:Glecaprevir;(33R,35S,91R,92R,5S,E)-5-(tert-butyl)-N-((1R,2R)-2-(difluoromethyl)-1-(((1-methylcyclopropyl)sulfonyl)carbamoyl)cyclopropyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35;Glecaprevir API;(1R,2R)-N-[[[(1R,2R)-2-[[4,4-Difluoro-4-(3-hydroxy-2-quinoxalinyl)-2-buten-1-yl]oxy]cyclopentyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]cyclopropanecarboxamide cyclic (1→2)-ether;ABT-493(Glecaprevir);CS-2616;ABT-493;ABT 493;ABT493;GLECAPREVIR;Glecaprevir(ABT-493)
CAS:1365970-03-1
MF:C38H46F4N6O9S
MW:838.87
EINECS:
Product Categories:
Mol File:1365970-03-1.mol
Glecaprevir Structure
Glecaprevir Chemical Properties
Melting point >186°C (dec.)
density 1.46±0.1 g/cm3(Predicted)
storage temp. Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility DMSO (Slightly), Methanol (Slightly)
pka4.46±0.40(Predicted)
form Solid
color White to Off-White
Safety Information
MSDS Information
Glecaprevir Usage And Synthesis
ApprovalOn 19 December 2016, AbbVie submitted a new drug application to the U.S. Food and Drug Administration for the glecaprevir/pibrentasvir (trade name Mavyret) regimen for the treatment of all major genotypes of chronic hepatitis C. On 3 August 2017 the FDA approved the combination for hepatitis C treatment. In Europe, it was approved on 17 August 2017 for the same indication, under the trade name Maviret.
UsesGlecaprevir is an antiviral drug used in the treatment of patients with hepatitis C virus (HCV) genotype 1-6, of special interest for the treatment of patients with chronic kidney disease also suffering from HCV.
UsesGlecaprevir (INN) is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that was identified jointly by AbbVie and Enanta Pharmaceuticals. It is being developed as a treatment of chronic hepatitis C infection in co-formulation with an HCV NS5A inhibitor pibrentasvir. Together they demonstrated potent antiviral activity against major HCV genotypes and high barriers to resistance in vitro.
Side effectsThe most common adverse effects, observed in at least 10% of phase 3 trial participants, were headache and fatigue.
Glecaprevir Preparation Products And Raw materials
Tag:Glecaprevir(1365970-03-1) Related Product Information
ABT-530 NBQX DISODIUM SALT SU14813 LOXO-292 Futibatinib (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylic acid (1R,2R)-1-amino-2-(difluoromethyl)-N-(1-methylcyclopropylsulfonyl)cyclopropanecarboxamide hydrochloride 3-(1,1-difluoroallyl)quinoxalin-2-ol methyl (33R,35S,91R,92R,5S,E)-5-(tert-butyl)-14,14-difluoro-4,7-dioxo-2,8,10-trioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopentanacyclotetradecaphan-12-ene-35-carboxylate 2-chloro-3-(1,1-difluoroallyl)quinoxaline